Conference
310 (PB298): Synergistic Anti-Tumor Effects of the Novel HDAC Inhibitor, ABT-301, with Immune Checkpoint Inhibitors in Colorectal Cancer Through Regulation of Immune Response and Anti-Angiogenesis
Authors
Tan KT; Lin MC; Hsu TA; Chang CF; Chang SM; Lin CT
Volume
211
Publisher
Elsevier
Publication Date
October 1, 2024
DOI
10.1016/j.ejca.2024.114823
Conference proceedings
European Journal of Cancer
ISSN
0959-8049